New Hampshire Trust

Position in BMY — Bristol Myers Squibb Co

CIK 1961742 CONCORD, NH

Position in BMY

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$571,992

-$30,080 QoQ

Shares Held

9,927

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,452

of 2,506 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

New Hampshire Trust holds $23,591,468 across 9 Drug Manufacturers - General names. BMY ranks #7 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	33,795	$8,504,172
2	MRK	Merck & Co., Inc.	54,175	$6,961,487
3	JNJ	Johnson & Johnson	15,285	$3,881,930
4	NVS	Novartis AG	7,170	$1,123,681
5	LLY	ELI LILLY & Co	933	$1,119,067
6	AMGN	Amgen Inc	2,237	$810,062
7	BMY	Bristol Myers Squibb Co This page	9,927	$571,992
8	PFE	Pfizer Inc	16,564	$398,861

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$571,992	9,927	0.0%	Shares	Sole	2026-07-27
2026-03-31	$602,072	9,927	0.0%	Shares	Sole	2026-04-20
2025-12-31	$535,462	9,927	-0.3%	Shares	Defined	2026-01-29
2025-09-30	$449,060	9,957	0.0%	Shares	Defined	2025-10-16
2025-06-30	$460,909	9,957	-1.7%	Shares	Defined	2025-07-31
2025-03-31	$617,523	10,125	+0.3%	Shares	Defined	2025-04-08
2024-12-31	$570,973	10,095	-1.8%	Shares	Defined	2025-01-16
2024-09-30	$532,042	10,283	0.0%	Shares	Defined	2024-10-17
2024-06-30	$427,052	10,283	-10.5%	Shares	Defined	2024-07-15
2024-03-31	$623,264	11,493	-2.6%	Shares	Defined	2024-04-09
2023-12-31	$605,354	11,798	-1.6%	Shares	Defined	2024-01-12
2023-09-30	$696,073	11,993	-0.6%	Shares	Defined	2023-10-17
2023-06-30	$771,876	12,070	-5.0%	Shares	Sole	2023-07-11
2023-03-31	$880,860	12,709	-2.2%	Shares	Sole	2023-04-18
2022-12-31	$934,774	12,992	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.